Goldman Sachs
NRX

Goldman Sachs’s NEPHROGENEX INC COM NRX Stock Holding History

Goldman Sachs’s Portfolio NRX Stock Details NRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-18,736
Closed -$9K – 7494
2016
Q1 		$9K Buy
+18,736
New +$15.6K ﹤0.01% 6923

Goldman Sachs's NRX Position: Q2 2016 in Review

Goldman Sachs sold out of NEPHROGENEX INC COM (NRX) in Q2 2016, closing a stake of 18,736 shares — an estimated $9K sold.

Goldman Sachs first reported a position in NRX in Q1 2016 and held it in 1 quarter. The position peaked at $9K in Q1 2016. 1 fund tracked by Wall St. Rank holds NRX as of Q2 2016.

  • Goldman Sachs reported no remaining NEPHROGENEX INC COM position as of Q2 2016 after selling out during the quarter.
  • Goldman Sachs sold 18,736 NEPHROGENEX INC COM shares in Q2 2016, an estimated $9K.
  • Goldman Sachs first reported a position in NEPHROGENEX INC COM in Q1 2016 and held it in 1 quarter.
  • Goldman Sachs's NEPHROGENEX INC COM position peaked at $9K in Q1 2016.
  • 1 fund tracked by Wall St. Rank held NEPHROGENEX INC COM as of Q2 2016.

Based on Goldman Sachs's 13F filing for Q2 2016, filed 15 Aug 2016.